title: Characterization of UDP-glucuronosyltransferases involved in glucuronidation of diethylstilbestrol in human liver and intestine.
abstract: Diethylstilbestrol (DES), a synthetic estrogen, is famous for its carcinogenic effects. Human exposure to this compound can occur frequently through dietary ingestion and medical treatment. Glucuronidation has been demonstrated to be a predominant metabolic pathway for DES in human. Therefore, glucuronidation metabolism may have a significant impact on its toxicities, and it is essential to clarify this metabolic pathway. Accordingly, this in vitro study is designed to characterize the UGTs involved in DES glucuronidation and, furthermore, to identify the roles of individual isoforms in the reaction in liver and intestine. Human liver microsomes (HLM) displayed much higher potential for DES glucuronidation than human intestinal microsomes (HIM). The intrinsic clearances in HLM and HIM were demonstrated to be 459 and 14 μL/min/mg protein, respectively. Assays with recombinant UGTs demonstrated that UGT1A1, -1A3, -1A8, and -2B7 could catalyze DES glucuronidation, among which UGT2B7 showed the highest affinity. Chemical inhibitors of UGT2B7 and UGT1A1/1A3 both displayed similar inhibition against the reaction in UGT2B7 and HLM. In addition, DES glucuronidation in individual HLM exhibited a large individual variability and strongly correlated to UGT2B7 activity. All evidence indicates that UGT2B7 may act as a major enzyme responsible for DES glucuronidation in human liver. For HIM, both UGT2B7 inhibitor and UGT1A1/1A3/1A8 inhibitor exerted moderate inhibition. It is suggested that although UGT2B7 contributes to DES glucuronidation in intestine, other UGTs may contribute equally. In summary, this study characterizes human UGTs involved in DES glucuronidation in human liver and intestine, which may be helpful for further study about DES-related toxicities.
authors.affiliation: Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
authors.forename: Liangliang
authors.initials: L
authors.lastname: Zhu
authors.forename: Guangbo
authors.initials: G
authors.lastname: Ge
authors.forename: Yong
authors.initials: Y
authors.lastname: Liu
authors.forename: Zhimou
authors.initials: Z
authors.lastname: Guo
authors.forename: Chengcheng
authors.initials: C
authors.lastname: Peng
authors.forename: Feng
authors.initials: F
authors.lastname: Zhang
authors.forename: Yunfeng
authors.initials: Y
authors.lastname: Cao
authors.forename: Jingjing
authors.initials: J
authors.lastname: Wu
authors.forename: Zhongze
authors.initials: Z
authors.lastname: Fang
authors.forename: Xinmiao
authors.initials: X
authors.lastname: Liang
authors.forename: Ling
authors.initials: L
authors.lastname: Yang
mesh_terms: D002273:Carcinogens / Q000378:metabolism*; D004054:Diethylstilbestrol / Q000378:metabolism*; D004968:Estrogens, Non-Steroidal / Q000378:metabolism*; D020719:Glucuronides / Q000378:metabolism; D014453:Glucuronosyltransferase / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008861:Microsomes / Q000378:metabolism
chemical_list: D002273:Carcinogens; D004968:Estrogens, Non-Steroidal; D020719:Glucuronides; D004054:Diethylstilbestrol; D014453:Glucuronosyltransferase